Firms Slam Fresh Price Cut Threats

Smaller German drugmakers have opposed any further government moves to cut medicines costs, following deep reductions in generic drug prices in recent months. Germany's mid-sized pharmaceutical companies have witnessed a frenzy of M&A activity in recent weeks, at a time when the so-called Economic Optimization of Pharmaceutical Care Act (AVWG) is introducing harsh cost cuts..

To read the full article, please take a trial.